$VVUS Recent News Vivus loss narrows as weight-loss

New Post Public Reply Private Reply Replies (0) Message Board

Jun 13, 2014 at 10:59 PM

$VVUS Recent News

Vivus loss narrows as weight-loss sales surge 6:03 p.m. May 5, 2014 - MarketWatch.com
Earnings, deals aid medical supplier, biopharmas on mixed market day 11:32 a.m. Oct. 11, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
What would Grumpy Cat short? 8:56 a.m. July 30, 2013 - The Trading Deck
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
Boardroom peace means a drop in shares for embattled Vivus 1:56 p.m. July 19, 2013 - Russ Britt
Vivus claims allies in proxy war, as does rogue investor 11:09 a.m. July 5, 2013 - Russ Britt
Vivus, rogue shareholder trade salvos as boardroom war heats up 4:52 p.m. June 25, 2013 - Russ Britt
Vivus shares drop as fight for control of company board heats up 4:06 p.m. June 24, 2013 - Russ Britt
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
Study shows Vivus' Qsymia may help sleep apnea 9:14 a.m. Nov. 12, 2012 - MarketWatch.com
Vivus shares slide on weak diet-drug sales 1:21 p.m. Nov. 6, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:14 p.m. Sept. 21, 2012 - Greg Morcroft
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Vivus expects Qsiva marketing rejection in Europe 7:48 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus shares fall 11%, top preopen decliner 7:35 a.m. Sept. 21, 2012 - Greg Morcroft

Vivus Suit Preserves Exclusivity Of Qsymia - For Now 2:56 p.m. Today - Seeking Alpha
Vivus sues Actavis 5:59 p.m. June 12, 2014 - Seeking Alpha
EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel 8:00 a.m. June 12, 2014 - TheStreet.com
Despite the Stumble, OREX Stock & Contrave Are Still Compelling 7:42 a.m. June 12, 2014 - InvestorPlace.com
Orexigen Irony: No VIVUS Bounce 4:25 p.m. June 11, 2014 - 247WallSt.com
Orexigen Obesity Drug Decision Delayed By FDA 10:55 a.m. June 11, 2014 - Investors Business Daily
Top Swing Trade Ideas for Wednesday June 11: Facebook, Vivus, More 9:37 a.m. June 11, 2014 - TheStreet.com
FDA Delays Decision On Orexigen Anti-Obesity Drug - What This Means To The Stock 9:28 a.m. June 11, 2014 - Seeking Alpha
Orexigen Shares Drop as FDA Delays Approval 7:17 a.m. June 11, 2014 - The Wall Street Journal Interactive Edition
FDA Delays Decision on Orexigen Obesity Pill by 3 Months 6:48 a.m. June 11, 2014 - TheStreet.com
Orexigen Investors Hope For FDA Approval 1:22 p.m. June 10, 2014 - Seeking Alpha
Orexigen Could Be A Double Edged Sword For Arena 5:22 p.m. June 9, 2014 - Seeking Alpha
Is Vivus About To Get Squeezed? 1:54 p.m. June 9, 2014 - benzinga.com
Binary event looming for Orexigen 1:54 p.m. June 9, 2014 - Seeking Alpha
Orexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision Wednesday 12:43 p.m. June 9, 2014 - TheStreet.com
Arena Pharmaceuticals: Strong Sell On Multiple Red Flags 1:15 p.m. June 6, 2014 - Seeking Alpha
Investors Are Shorting VIVUS (VVUS) Stock: Is A Short Cover Coming? - Tale of the Tape 9:00 a.m. June 3, 2014 - Zacks.com
Belviq Sales Climb - Are Ads Effective? 4:46 p.m. May 30, 2014 - Seeking Alpha
A Vivus Buyout? Fat Chance And A Good Time To Short 12:30 p.m. May 30, 2014 - Seeking Alpha
Cramer's Lightning Round - Linn Energy Has Lost Its Way (5/29/14) 6:28 a.m. May 30, 2014 - Seeking Alpha

VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents 4:33 p.m. June 12, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 7:01 a.m. June 12, 2014 - Marketwire
Technical Data on Top Gainers -- Research on VIVUS, Magnum Hunter Resources, Xenoport, and Media General 7:10 a.m. May 29, 2014 - PR Newswire - PRF
Avanafil Clinical Data to Be Presented at American Urological Association 7:02 a.m. May 19, 2014 - Marketwire
VIVUS Announces Qsymia Presentation at the American Association of Clinical Endocrinologists (AACE) 7:02 a.m. May 15, 2014 - Marketwire
VIVUS to Present at Upcoming Investor Conference 4:32 p.m. May 8, 2014 - Marketwire
Active Stocks at a Glance -- Research on Oi S.A., Hyperdynamics, Vivus, and EMC Corp. 8:00 a.m. May 7, 2014 - PR Newswire - PRF
VIVUS Reports First Quarter 2014 Financial Results 6:25 a.m. May 7, 2014 - Marketwire
VIVUS Announces Date of First Quarter 2014 Update and Financial Results Conference Call 7:02 a.m. April 29, 2014 - GlobeNewswire
Avanafil Clinical Data to Be Presented at European Association of Urology 7:01 a.m. April 11, 2014 - Marketwire
Three VIVUS Directors Not Standing for Re-Election 5:01 p.m. April 8, 2014 - Marketwire
Food & Beverage Companies Advancing in the Consumer Goods Sector - Company Focuses on Strategic Growth Initiatives for 2014 and Beyond 9:05 a.m. April 3, 2014 - PR Newswire - PRF
VIVUS to Present at Upcoming Investor Conference 7:02 a.m. April 3, 2014 - Marketwire
Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia 7:03 a.m. March 25, 2014 - Marketwire
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Shari Belafonte Partners With VIVUS to Encourage Adults to Speak With Their Doctors About Losing Weight and Treatment Options Now Available 7:02 a.m. March 19, 2014 - Marketwire
Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand 10:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
VIVUS Reports Fourth Quarter and Year-End 2013 Financial Results 5:00 p.m. Feb. 24, 2014 - GlobeNewswire
VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and Conference Call 8:00 a.m. Feb. 19, 2014 - GlobeNewswire
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (avanafil) 8:05 a.m. Jan. 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....